Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus

被引：1
|
作者：
Elsharkawy, A. M. [1 ]
机构：
[1] Univ Hosp Birmingham, Liver Unit, Birmingham, W Midlands, England
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 05期
关键词：
D O I：
10.1111/apt.12610
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：543 / 544
页数：2
相关论文
共 50 条
  • [41] Daily Low-dose Tacrolimus Is a Safe and Effective Immunosuppressive Regimen During Telaprevir-based Triple Therapy for Hepatitis C Virus Recurrence After Liver Transplant
    Papadopoulos-Koehn, Angela
    Achterfeld, Anne
    Paul, Andreas
    Canbay, Ali
    Timm, Joerg
    Jochum, Christoph
    Gerken, Guido
    Herzer, Kerstin
    TRANSPLANTATION, 2015, 99 (04) : 841 - 847
  • [42] Viral Hepatitis ( plus Antiviral Therapy) Efficacy of telaprevir-based triple therapy for genotype 1 hepatitis patients in Japan
    Sasaki, Masato
    Yoshida, Kenichi
    Inamura, Kazuki
    Obata, Masahiro
    Yoshinari, Motonari
    Idegami, Junko
    Tanaka, Hideki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 423 - 423
  • [43] Dermatological side-effects of telaprevir-based triple therapy for chronic hepatitis C in phase III trials in Japan
    Torii, Hideshi
    Sueki, Hirohiko
    Kumada, Hiromitsu
    Sakurai, Yuko
    Aoki, Keiji
    Yamada, Ichimaro
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2013, 40 (08): : 587 - 595
  • [44] Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C
    Senates, Ebubekir
    Colak, Yasar
    Yesil, Atakan
    Tuncer, Ilyas
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2015, 26 (03): : 283 - 283
  • [45] Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data
    Werner, Christoph R.
    Egetemeyr, Daniel P.
    Lauer, Ulrich M.
    Nadalin, Silvio
    Koenigsrainer, Alfred
    Malek, Nisar P.
    Berg, Christoph P.
    LIVER TRANSPLANTATION, 2012, 18 (12) : 1464 - 1470
  • [46] Efficacy and Safety of Telaprevir-Based Antiviral Treatment for Elderly Patients with Hepatitis C Virus
    Takita, Masahiro
    Hagiwara, Satoru
    Kudo, Masatoshi
    Kono, Masashi
    Chishina, Hirokazu
    Arizumi, Tadaaki
    Kitai, Satoshi
    Yada, Norihisa
    Inoue, Tatsuo
    Minami, Yasunori
    Ueshima, Kazuomi
    ONCOLOGY, 2014, 87 : 110 - 117
  • [47] VIROLOGICAL RESPONSE AT WEEK 6 OF TELAPREVIR-BASED TRIPLE THERAPY IS THE MOST EFFECTIVE PREDICTOR OF CHRONIC HEPATITIS C TREATMENT OUTCOME
    Hiramine, S.
    Ogawa, E.
    Furusyo, N.
    Nakamura, M.
    Kajiwara, E.
    Nomura, H.
    Dohmen, K.
    Takahashi, K.
    Satoh, T.
    Azuma, K.
    Kawano, A.
    Tanabe, Y.
    Kotoh, K.
    Shimoda, S.
    Hayashi, J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S474 - S474
  • [48] SERUM INTERLEUKIN-6 LEVELS DURING TREATMENT CORRELATE WITH RESISTANCE TO TELAPREVIR-BASED TRIPLE THERAPY IN CHRONIC HEPATITIS C
    Asahina, Y.
    Nakagawa, M.
    Taniguchi, M.
    Kawai, F.
    Fujiki, J.
    Otani, T.
    Yamanaka, H.
    Murakawa, M.
    Nitta, S.
    Kitazume, A.
    Watanabe, T.
    Sakurai, Y.
    Azuma, S.
    Kakinuma, S.
    Watanabe, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S321 - S321
  • [49] Mechanism of renal dysfunction in the early phase of telaprevir-based triple therapy
    Sakane, Sadatsugu
    Ishida, Hisashi
    Fukutomi, Keisuke
    Kimura, Keiichi
    Sugimoto, Aya
    Hibino, Kenji
    Tamura, Takeshi
    Iwasaki, Tetsuya
    Iwasaki, Ryuichiro
    Hasegawa, Hiroko
    Sakakibara, Yuko
    Yamada, Takuya
    Yamato, Masafumi
    Nakazuru, Shoichi
    Toyama, Takashi
    Ito, Takahito
    Mita, Eiji
    HEPATOLOGY, 2013, 58 : 1114A - 1114A
  • [50] Reduced-Dose Telaprevir-Based Triple Antiviral Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation
    Ikegami, Toru
    Yoshizumi, Tomoharu
    Kato, Masaki
    Yamamoto, Satomi
    Fukuhara, Takasuke
    Matsuura, Yoshiharu
    Nakamura, Shota
    Itoh, Shinji
    Shirabe, Ken
    Maehara, Yoshihiko
    TRANSPLANTATION, 2014, 98 (09) : 994 - 999
12345